FVIII, the blood clotting protein missing in hemophilia A, adopts multiple shapes, making it more likely to be targeted by ...

It can be tempting to compare your life with others, columnist Cazandra Campos-MacDonald writes, but the grass isn't always greener.

In part two of a series, columnist Jennifer Lynne talks with Chip Hailey about his experience receiving gene therapy for hemophilia B.

Columnist Joe MacDonald learns to step back as his son with hemophilia tackles some of the hard lessons of becoming independent.

A man’s acquired hemophilia coincided with a rare liver disease, a connection that had not been reported before, per a case ...

A therapy to boost the production of regulatory T-cells prevented inhibitor formation in a mouse model of hemophilia A, per a ...

As her sons with hemophilia step into their futures prepared for what comes, columnist Cazandra Campos-MacDonald is embracing ...

The FDA has extended its approval of Jivi to cover the therapy's use in children with hemophilia A ages 7 years and older.

Columnist G Shellye Horowitz is looking for a new factor product after the one she was trying had disappointing results.

Columnist G Shellye Horowitz argues for a new way of classifying hemophilia severity that takes both genotype and phenotype into account.

Columnist Alliah Czarielle notes how her husband with hemophilia finds freedom by using mobility aids after an ankle bleed.